skip to main content
Idioma:
Refinado por: assunto: Estudos Randomizados remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+ advanced breast cancer: BOLERO-1
Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+ advanced breast cancer: BOLERO-1
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+ advanced breast cancer: BOLERO-1

Sara A. Hurvitz Fabrice Andre; Zefei Jiang; Zhimin Shao; Silvia P Neciosup; Max S Mano; Ling-Min Tseng; Qingyuan Zhang; Kunwei Shen; Donggeng Liu; Lydia M Dreosti; Jifeng Feng; Howard A Burris; Masakazu Toi; Marc E Buyse; David Cabaribere; Mary-Ann Lindsay; Tiffany Kunz; Shantha Rao; Lida B Pacaud; Tetiana Taran; Dennis Slamon; Annual CTRC-AACR San Antonio Breast Cancer Symposium (37. 2014 San Antonio, TX)

Cancer Research Baltimore v. 75, abst. S6-01, May, 2015

Baltimore 2015

Acesso online. A biblioteca também possui exemplares impressos.

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Zhang, Q
  2. Cabaribere, D
  3. Rao, S
  4. Buyse, M
  5. Dreosti, L

Neste Assunto:

  1. Estudos Randomizados
  2. Neoplasias Mamárias (Fisiopatologia)
  3. Placebo
  4. Estudos Randomizados

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.